Publications by authors named "Mark Bunker"

Claim this Profile
C
Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial report.
Harold A Sackeim, Charles R Conway, Scott T Aaronson, Mark T Bunker, Charles Gordon

J Affect Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report.
Scott T Aaronson, Charles R Conway, Charles Gordon, Ying-Chieh Lisa Lee, Mark S George, Mark T Bunker

J Clin Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression.
Charles R Conway, A John Rush, Charles Gordon, Sheldon H Preskorn, Harold A Sackeim, Mark T Bunker

J Mood Anxiety Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial.
A John Rush, Charles R Conway, Scott T Aaronson, Mark S George, Patricio Riva-Posse, Mark T Bunker

Brain Stimul· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Mark S George, John Zajecka, Mark T Bunker

Brain Stimul· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image-Guided Stereotactic Body Radiotherapy (SBRT) with Enhanced Visualization of Tumor and Hepatic Parenchyma in Patients with Primary and Metastatic Liver Malignancies.
Alexander V Kirichenko, Danny Lee, Patrick Wagner, Seungjong Oh, Hannah Lee, Mark Bunker

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood Associated With t(1;22)(p22;q11.2) Mutation.
Lane Lerner, Sushanth Sreenivasan, Chelsea Peterson, Maitreyee Rai, Pragnan Kancharla, Mark Bunker

J Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2).
Harold A Sackeim, Scott T Aaronson, Mark T Bunker, Charles R Conway, Mark S George

J Psychiatr Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Walter Duffy, Mary Stedman, Mark T Bunker

Brain Stimul· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Treatment of Refractory Post-Transplant Lymphoproliferative Disorder With Chimeric Antigen Receptor T-Cell Therapy in a Heart Transplant Recipient.
Katherine Hickmann, Ryan Sweeney, Chelsea Peterson, Kathleen Faringer, Madeline Riley, Mark Bunker

J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects.
Scott T Aaronson, Harold A Sackeim, Mei Jiang, Sarah Badejo, Teresa Greco, Mark T Bunker

Aust N Z J Psychiatry· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic gastritis in adult complicated by gastric ulcer perforation.
Joseph A Tharakan, Julianna P O'Toole, Harmeet K Kharoud, Mark L Bunker, Jennifer Y Chen

J Surg Case Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life.
Harold A Sackeim, A John Rush, Teresa Greco, Mei Jiang, Sarah Badejo, Mark T Bunker

Psychol Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical research challenges posed by difficult-to-treat depression.
A John Rush, Harold A Sackeim, Charles R Conway, Mark T Bunker, Steven D Hollon

Psychol Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic enucleation of a biliary adenofibroma.
Elizabeth Blears, Tadahiro Uemura, Mark Bunker

BMJ Case Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Celiac Disease With Pembrolizumab.
Ashish Sethi, Alexander Helfand, Lame Balikani, Mark Bunker, Gene Finley

Cureus· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Long and Winding Road of Vagus Nerve Stimulation: Challenges in Developing an Intervention for Difficult-to-Treat Mood Disorders.
Harold A Sackeim, Maxine Dibué, Mark T Bunker, A John Rush

Neuropsychiatr Dis Treat· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment.
Charles R Conway, Bryan Olin, Scott T Aaronson, Harold A Sackeim, Mark Bunker

Contemp Clin Trials· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulminant Herpes Simplex Hepatitis Secondary to Adalimumab in Crohn's Disease: A Case Report.
Kanika Goel, Mark Bunker, Anna Balog, Jan F Silverman

Clin Med Insights Case Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).
Harold A Sackeim, Scott T Aaronson, Mark T Bunker, Charles R Conway, Mark A Demitrack

J Psychiatr Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Crescentic Glomeruli in Acute Kidney Injury with Rheumatoid Arthritis.
Ali Ayaash, Dipesh Maan, Anastasios Kapetanos, Mark Bunker, Mary Chester Wasko

Case Rep Nephrol Dial· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression.
Arun Kumar, Mark T Bunker, Scott T Aaronson, Charles R Conway, Anthony J Rothschild

Neuropsychiatr Dis Treat· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful management of proliferative glomerulonephritis with monoclonal immune deposits with combined immunosuppressive therapy.
Dipesh Maan, Barbara Clark, Mark Bunker, Swati Arora

BMJ Case Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis